214 related articles for article (PubMed ID: 36550755)
1. Use of specific contrast-enhanced CT regions of interest to differentiate renal oncocytomas from small clear cell and chromophobe renal cell carcinomas.
Qu JY; Jiang H; Wang XF; Song XH; Hao CJ
Diagn Interv Radiol; 2022 Nov; 28(6):555-562. PubMed ID: 36550755
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of renal angiomyolipoma without visible fat from small clear cell renal cell carcinoma by using specific region of interest on contrast-enhanced CT: a new combination of quantitative tools.
Wang X; Song G; Jiang H
Cancer Imaging; 2021 Jul; 21(1):47. PubMed ID: 34225784
[TBL] [Abstract][Full Text] [Related]
3. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
[TBL] [Abstract][Full Text] [Related]
4. CT differentiation of the oncocytoma and renal cell carcinoma based on peripheral tumor parenchyma and central hypodense area characterisation.
Qu J; Zhang Q; Song X; Jiang H; Ma H; Li W; Wang X
BMC Med Imaging; 2023 Jan; 23(1):16. PubMed ID: 36707788
[TBL] [Abstract][Full Text] [Related]
5. Radiomics analysis based on single phase and different phase combinations of radiomics features from tri-phasic CT to distinguish renal oncocytoma from chromophobe renal cell carcinoma.
Yang S; Jian Y; Yang F; Liu R; Zhang W; Wang J; Tan X; Wu J; Chen Y; Zhou X
Abdom Radiol (NY); 2024 Jan; 49(1):182-191. PubMed ID: 37907684
[TBL] [Abstract][Full Text] [Related]
6. A CT-based radiomics nomogram for differentiation of renal oncocytoma and chromophobe renal cell carcinoma with a central scar-matched study.
Li X; Ma Q; Nie P; Zheng Y; Dong C; Xu W
Br J Radiol; 2022 Jan; 95(1129):20210534. PubMed ID: 34735296
[TBL] [Abstract][Full Text] [Related]
7. Differentiation between renal oncocytomas and chromophobe renal cell carcinomas using dynamic contrast-enhanced computed tomography.
Guo K; Ren S; Cao Y; Zhang H; Zhang Y; Gu X; Wang Z
Abdom Radiol (NY); 2021 Jul; 46(7):3309-3316. PubMed ID: 33710383
[TBL] [Abstract][Full Text] [Related]
8. Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT.
Gentili F; Bronico I; Maestroni U; Ziglioli F; Silini EM; Buti S; de Filippo M
Radiol Med; 2020 Dec; 125(12):1280-1287. PubMed ID: 32385827
[TBL] [Abstract][Full Text] [Related]
9. Value of radiomics in differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.
Li Y; Huang X; Xia Y; Long L
Abdom Radiol (NY); 2020 Oct; 45(10):3193-3201. PubMed ID: 31664486
[TBL] [Abstract][Full Text] [Related]
10. Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms.
Dhyani M; Grajo JR; Rodriguez D; Chen Z; Feldman A; Tambouret R; Gervais DA; Arellano RS; Hahn PF; Samir AE
Abdom Radiol (NY); 2017 Jun; 42(6):1734-1743. PubMed ID: 28197683
[TBL] [Abstract][Full Text] [Related]
11. Differential diagnosis of renal oncocytoma and chromophobe renal cell carcinoma using CT features: a central scar-matched retrospective study.
Li X; Nie P; Zhang J; Hou F; Ma Q; Cui J
Acta Radiol; 2022 Feb; 63(2):253-260. PubMed ID: 33497276
[TBL] [Abstract][Full Text] [Related]
12. Four-phase computed tomography helps differentiation of renal oncocytoma with central hypodense areas from clear cell renal cell carcinoma.
Qu JY; Jiang H; Song XH; Wu JK; Ma H
Diagn Interv Radiol; 2023 Mar; 29(2):205-211. PubMed ID: 36960636
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of renal oncocytoma and renal clear cell carcinoma using relative CT enhancement ratio.
Ren A; Cai F; Shang YN; Ma ES; Huang ZG; Wang W; Lu Y; Zhang XZ
Chin Med J (Engl); 2015 Jan; 128(2):175-9. PubMed ID: 25591558
[TBL] [Abstract][Full Text] [Related]
14. A triple-classification for differentiating renal oncocytoma from renal cell carcinoma subtypes and CK7 expression evaluation: a radiomics analysis.
Yu Z; Ding J; Pang H; Fang H; He F; Xu C; Li X; Ren K
BMC Urol; 2022 Sep; 22(1):147. PubMed ID: 36096829
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Measurement on Contrast-Enhanced CT Distinguishes Small Clear Cell Renal Cell Carcinoma From Benign Renal Tumors: A Multicenter Study.
Luo S; Lin W; Wu J; Zhang W; Kui X; Lai S; Wei R; Pang X; Wang Y; He C; Liu J; Yang R
Acad Radiol; 2024 Apr; 31(4):1460-1471. PubMed ID: 37945492
[TBL] [Abstract][Full Text] [Related]
16. Clear cell renal cell carcinoma: CT-based radiomics features for the prediction of Fuhrman grade.
Shu J; Tang Y; Cui J; Yang R; Meng X; Cai Z; Zhang J; Xu W; Wen D; Yin H
Eur J Radiol; 2018 Dec; 109():8-12. PubMed ID: 30527316
[TBL] [Abstract][Full Text] [Related]
17. Differential diagnosis of chromophobe renal cell carcinoma and papillary renal cell carcinoma with dual-energy spectral computed tomography.
Wang D; Huang X; Bai L; Zhang X; Wei J; Zhou J
Acta Radiol; 2020 Nov; 61(11):1562-1569. PubMed ID: 32088966
[TBL] [Abstract][Full Text] [Related]
18. Voxel-based whole-lesion enhancement parameters: a study of its clinical value in differentiating clear cell renal cell carcinoma from renal oncocytoma.
Chen F; Gulati M; Hwang D; Cen S; Yap F; Ugwueze C; Varghese B; Desai M; Aron M; Gill I; Duddalwar V
Abdom Radiol (NY); 2017 Feb; 42(2):552-560. PubMed ID: 27595574
[TBL] [Abstract][Full Text] [Related]
19. CT-based multi-phase Radiomic models for differentiating clear cell renal cell carcinoma.
Chen M; Yin F; Yu Y; Zhang H; Wen G
Cancer Imaging; 2021 Jun; 21(1):42. PubMed ID: 34162442
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of CT appearances in renal oncocytoma and chromophobe renal cell carcinoma.
Wu J; Zhu Q; Zhu W; Chen W; Wang S
Acta Radiol; 2016 Apr; 57(4):500-6. PubMed ID: 25972369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]